INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2017

A review concludes red yeast rice is not an acceptable substitution for statins due to variability in monacolin K, unknown risks, and potential toxicity.

This review evaluates the therapeutic and side effects of red yeast rice, a supplement containing Monascus purpureus and monacolin K (chemically identical to lovastatin). The author reports that red yeast rice preparations exhibit large variability in monacolin K concentration and types, making dose-related efficacy and side-effect risks practically impossible to predict. Additionally, other ingredients in red yeast rice are potentially toxic, and the FDA has issued warnings due to lack of standardized preparations and safety assurances. Based on clinical trial results and literature, the author argues red yeast rice is not an acceptable substitution for statins.

Study type
Narrative review
Who was studied
Hypercholesterolemic patients
What was measured
Efficacy, side effects, variability in monacolin K content, and safety

THE PAPER

Red Yeast Rice Preparations: Are They Suitable Substitutions for Statins?

Dujovne CA. Am J Med, 2017.

PubMed 28601545 ↗DOI 10.1016/j.amjmed.2017.05.013 ↗

Heart & arteriesFood safety & contaminants

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.